EXTL3功能异常被确定为严重家族性强直性脊柱炎异常骨发育的驱动因素
该研究在一个严重强直性脊柱炎(AS)家系中通过全基因组连锁分析和全外显子测序鉴定出EXTL3罕见错义变异,并构建Extl3突变 knock-in 小鼠进行功能验证。小鼠出现骶髂关节结构异常、骨样组织堆积和早期关节桥接,机制涉及Wnt信号激活和硫酸乙酰肝素(HS)代谢紊乱。研究提示EXTL3是AS结构严重性的遗传修饰因子,HS通路可能成为治疗靶点。
要点
- EXTL3罕见错义变异在严重家族性AS患者中鉴定出,为结构严重性的遗传修饰因子。
- Extl3突变小鼠出现骶髂关节结构异常、骨样组织堆积和早期关节桥接。
- 机制涉及Wnt信号激活、HS累积增加和乙酰肝素酶表达增强。
核心结论
- EXTL3介导的HS代谢失调是连接异常骨重塑与病理性骨化的新机制。
- EXTL3是AS结构严重性的遗传修饰因子,HLA-B27主要决定疾病易感性。
- HS相关通路可能成为AS结构进展的潜在治疗靶点。
研究设计与样本
- 在严重AS大家系中进行全基因组连锁分析和全外显子测序。
- 构建携带所鉴定EXTL3变异的杂合 knock-in 小鼠。
- 采用microCT、组织学、转录组学、原代成骨细胞和软骨细胞培养及HS代谢生化分析进行表征。
主要发现
- 在受累家庭成员中鉴定出EXTL3罕见错义变异,EXTL3是HS生物合成关键酶。
- Extl3mut/+小鼠出现骶髂关节结构异常、骨样组织堆积和早期关节桥接,伴骨小梁结构受损。
- 突变加速软骨细胞肥大,同时延迟成骨细胞成熟和矿化。
- 上述改变与Wnt信号激活、HS累积增加、乙酰肝素酶表达增强及糖胺聚糖稳态改变相关。
临床怎么用
- EXTL3变异可能有助于识别AS结构进展风险较高的患者。
- HS代谢通路可作为AS病理性骨化治疗干预的潜在方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Pathological ossification leading to spinal ankylosis is a hallmark of ankylosing spondylitis (AS), yet its molecular mechanisms remain poorly understood. We investigated the genetic basis and functional consequences of severe familial AS to identify pathways driving structural progression. METHODS: Genome-wide linkage analysis and whole-exome sequencing were performed in a multiplex family with severe AS. A heterozygous knock-in mouse carrying the identified EXTL3 variant was generated and characterized using microCT, histology, transcriptomics, primary osteoblast and chondrocyte cultures, and biochemical analyses of heparan sulfate (HS) metabolism. RESULTS: A rare missense variant in EXTL3, a key enzyme involved in HS biosynthesis, was identified in affected family members. Extl3mut/+ mice developed sacroiliac structural abnormalities, osteoid accumulation and early joint bridging, together with impaired trabecular bone architecture. Mechanistically, the mutation accelerated chondrocyte hypertrophy while delaying osteoblast maturation and mineralization. These changes were associated with activation of Wnt signalling, increased HS accumulation, enhanced heparanase expression and altered glycosaminoglycan homeostasis. Collectively, these findings identify EXTL3-mediated HS dysregulation as a novel mechanism linking abnormal bone remodelling to pathological ossification. CONCLUSIONS: Our study identifies EXTL3 as a genetic modifier of structural severity in AS and reveals a previously unrecognised role for HS metabolism in pathological ossification. These findings support a model in which HLA-B27 primarily confers disease susceptibility, whereas rare variants such as EXTL3 contribute to structural progression, highlighting HS-related pathways as potential therapeutic targets.
引用
- Hilliquin S, Fogel O, Tissier M, et al. EXTL3 dysfunction identified as a driver of aberrant bone development in severe familial ankylosing spondylitis. Ann Rheum Dis. 2026. PMID: 42562756. doi:10.1016/j.ard.2026.06.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。